Michael B. Livingston
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Co-authors
- Matthew M. CooneyAnthony EliasGary K. SchwartzRobert G. MakiMark AgulnikScott M. SchuetzeSamir D. UndeviaMary Louise Keohan
- Topics
- Sarcoma Diagnosis and Treatment (19 papers)Vascular Tumors and Angiosarcomas (9 papers)Cardiac tumors and thrombi (7 papers)
- Partner nations
- United StatesUnited KingdomUkraine
In The Last Decade
Michael B. Livingston
27 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 1.0k
- Oncology 793
- Cardiology and Cardiovascular Medicine 358
- Pathology and Forensic Medicine 234
- Molecular Biology 172
Countries citing papers authored by Michael B. Livingston
This map shows the geographic impact of Michael B. Livingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Livingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Livingston more than expected).
Fields of papers citing papers by Michael B. Livingston
This network shows the impact of papers produced by Michael B. Livingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Livingston. The network helps show where Michael B. Livingston may publish in the future.
Co-authorship network of co-authors of Michael B. Livingston
This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Livingston. A scholar is included among the top collaborators of Michael B. Livingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Livingston. Michael B. Livingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 30 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 174 | |
| 7 | 10 | |
| 8 | 48 | |
| 9 | 4 | |
| 10 | 12 | |
| 11 | 29 | |
| 12 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialbreakdown → | 436 |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 14 | |
| 16 | 19 | |
| 17 | 2 | |
| 18 | 429 | |
| 19 | 3 | |
| 20 | 7 |
About Michael B. Livingston
Michael B. Livingston is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (19 papers), Vascular Tumors and Angiosarcomas (9 papers) and Cardiac tumors and thrombi (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Oncology (793 citations) and Cardiology and Cardiovascular Medicine (358 citations). Michael B. Livingston has collaborated with scholars based in United States, United Kingdom and Ukraine. Frequent co-authors include Matthew M. Cooney, Anthony Elias, Gary K. Schwartz, Robert G. Maki, Mark Agulnik, Scott M. Schuetze, Samir D. Undevia, Mary Louise Keohan, David R. D’Adamo and Ilaria Conti. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.